Launched some three years ago to provide the temporary removal of frown lines between the eyebrows, Jeuveau is much like industry leader Botox. The company also has an enhanced product in mid-stage development that would provide the first multi-strength neurotoxin in this market. The equity currently trades right around ten bucks a share. Option Strategy:Here is how one can initiate a position in EOLS via a covered call strategy. This strategy provides nearly 25% of downside protection and some 30% of upside potential even if the stock just trades sideways over the next seven months.

Source: Wall Street Journal September 18, 2022 17:10 UTC